Form 8-K - Current report:
SEC Accession No. 0001104659-25-024450
Filing Date
2025-03-17
Accepted
2025-03-17 16:30:39
Documents
13
Period of Report
2025-03-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259469d1_8k.htm   iXBRL 8-K 26985
  Complete submission text file 0001104659-25-024450.txt   200199

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lptx-20250312.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20250312_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20250312_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259469d1_8k_htm.xml XML 3676
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 25744973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)